Total Payments
$14,776
2022 Payments
$133.31
Companies
14
Transactions
52
Medicare Patients
7,226
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$13,500 (91.4%)
Food & Beverage$1,262 (8.5%)
Education$13.89 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,500 | 1 | 91.4% |
| Food and Beverage | $1,262 | 50 | 8.5% |
| Education | $13.89 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $13,500 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $246.42 | 13 | $0 (2021) |
| Amgen Inc. | $223.60 | 9 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $166.20 | 7 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $157.83 | 8 | $0 (2018) |
| Mallinckrodt Hospital Products Inc. | $119.42 | 1 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $97.84 | 1 | $0 (2017) |
| PFIZER INC. | $87.71 | 5 | $0 (2020) |
| Abbott Laboratories | $59.52 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $36.98 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $133.31 | 2 | Mallinckrodt Hospital Products Inc. ($119.42) |
| 2021 | $13,513 | 2 | Medtronic, Inc. ($13,500) |
| 2020 | $130.82 | 6 | Janssen Pharmaceuticals, Inc ($44.78) |
| 2019 | $325.19 | 13 | E.R. Squibb & Sons, L.L.C. ($132.57) |
| 2018 | $200.59 | 10 | E.R. Squibb & Sons, L.L.C. ($76.85) |
| 2017 | $473.16 | 19 | Novartis Pharmaceuticals Corporation ($134.20) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/06/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/16/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $119.42 | General |
| Category: IMMUNOLOGY | ||||||
| 09/21/2021 | Medtronic, Inc. | iPro2 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $13,500.00 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 01/13/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.07 | General |
| Category: Cardiovascular | ||||||
| 12/03/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/12/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/14/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.93 | General |
| Category: Cardiovascular | ||||||
| 09/10/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/04/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/12/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: DIABETES | ||||||
| 12/04/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/12/2019 | Abbott Laboratories | Accent Pacemaker (Device) | Food and Beverage | In-kind items and services | $59.52 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/01/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.25 | General |
| Category: Cardiovascular | ||||||
| 08/22/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $39.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/22/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.00 | General |
| Category: Cardiovascular | ||||||
| 07/25/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/17/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Cardiology | ||||||
| 06/19/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.25 | General |
| Category: Cardiovascular | ||||||
| 03/29/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Cardiovascular | ||||||
| 03/20/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: Cardiology | ||||||
| 02/15/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.47 | General |
| Category: Cardiovascular | ||||||
| 02/15/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.60 | General |
| Category: Cardiovascular | ||||||
| 01/30/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Cardiovascular | ||||||
| 10/17/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.86 | General |
| Category: Cardiovascular | ||||||
| 09/12/2018 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,068 | 5,040 | $498,980 | $171,013 |
| 2022 | 27 | 1,398 | 6,316 | $661,539 | $240,524 |
| 2021 | 43 | 2,042 | 8,436 | $772,778 | $312,124 |
| 2020 | 49 | 2,718 | 9,270 | $852,256 | $332,860 |
Total Patients
7,226
Total Services
29,062
Medicare Billing
$1.1M
Procedure Codes
136
All Medicare Procedures & Services
136 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 800 | $199,739 | $86,376 | 43.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 20 | 37 | $55,500 | $15,873 | 28.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 84 | 84 | $67,200 | $15,375 | 22.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 65 | 65 | $12,251 | $9,911 | 80.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 23 | 144 | $14,400 | $8,325 | 57.8% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 80 | 213 | $15,975 | $8,194 | 51.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 107 | 451 | $38,264 | $5,491 | 14.4% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 19 | 32 | $6,400 | $4,914 | 76.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 104 | 443 | $6,645 | $3,721 | 56.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 104 | 430 | $19,350 | $3,272 | 16.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 104 | 326 | $14,670 | $3,104 | 21.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 47 | 49 | $2,470 | $1,763 | 71.4% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 103 | 444 | $4,440 | $1,709 | 38.5% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 44 | 46 | $2,300 | $1,450 | 63.1% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 20 | 20 | $2,096 | $728.20 | 34.7% |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | Office | 2023 | 20 | 1,439 | $28,780 | $591.93 | 2.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 17 | 17 | $8,500 | $213.01 | 2.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 111 | 897 | $224,250 | $101,949 | 45.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 28 | 56 | $84,000 | $25,459 | 30.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 36 | 278 | $27,800 | $16,895 | 60.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 85 | 87 | $69,600 | $16,181 | 23.2% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2022 | 80 | 277 | $20,775 | $10,732 | 51.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 68 | 68 | $13,124 | $10,696 | 81.5% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 41 | 41 | $17,700 | $10,294 | 58.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 109 | 457 | $38,845 | $5,710 | 14.7% |
About Dr. Subhash Malhotra, M.D
Dr. Subhash Malhotra, M.D is a Cardiovascular Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578576963.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Subhash Malhotra, M.D has received a total of $14,776 in payments from pharmaceutical and medical device companies, with $133.31 received in 2022. These payments were reported across 52 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($13,500).
As a Medicare-enrolled provider, Malhotra has provided services to 7,226 Medicare beneficiaries, totaling 29,062 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 136 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Brooklyn, NY
- Active Since 08/15/2006
- Last Updated 05/09/2008
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1578576963
Products in Payments
- iPro2 (Device) $13,500
- ELIQUIS (Drug) $309.15
- XARELTO (Drug) $166.20
- ENTRESTO (Drug) $157.83
- ACTHAR (Biological) $119.42
- Corlanor (Drug) $117.89
- Repatha (Biological) $105.71
- Strensiq (Drug) $97.84
- Accent Pacemaker (Device) $59.52
- CHANTIX (Drug) $24.98
- NORTHERA (Drug) $23.81
- LINZESS (Drug) $21.55
- Vascepa (Drug) $21.37
- PRADAXA (Drug) $18.60
- JARDIANCE (Drug) $18.38
- FARXIGA (Drug) $13.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brooklyn
Dr. Felix Yang, M.d, M.D
Cardiovascular Disease — Payments: $599,451
Cardiovascular Disease $599,451
Ozgen Dogan, Md, MD
Cardiovascular Disease — Payments: $367,116
Cardiovascular Disease $367,116
Dr. Adam Budzikowski, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $346,063
Cardiovascular Disease $346,063
Dr. Peter Rouvelas, M.d, M.D
Cardiovascular Disease — Payments: $339,378
Cardiovascular Disease $339,378
Dr. Ronald Wharton, M.d, M.D
Cardiovascular Disease — Payments: $298,083
Cardiovascular Disease $298,083
Dr. Sorin Brener, Md, MD
Cardiovascular Disease — Payments: $225,799
Cardiovascular Disease $225,799